Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization
Open Access
- 29 August 2016
- journal article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 32 (17) , i455-i463
Abstract
Motivation : A key goal of computational personalized medicine is to systematically utilize genomic and other molecular features of samples to predict drug responses for a previously unseen sample. Such predictions are valuable for developing hypotheses for selecting therapies tailored for individual patients. This is especially valuable in oncology, where molecular and genetic heterogeneity of the cells has a major impact on the response. However, the prediction task is extremely challenging, raising the need for methods that can effectively model and predict drug responses. Results : In this study, we propose a novel formulation of multi-task matrix factorization that allows selective data integration for predicting drug responses. To solve the modeling task, we extend the state-of-the-art kernelized Bayesian matrix factorization (KBMF) method with component-wise multiple kernel learning. In addition, our approach exploits the known pathway information in a novel and biologically meaningful fashion to learn the drug response associations. Our method quantitatively outperforms the state of the art on predicting drug responses in two publicly available cancer datasets as well as on a synthetic dataset. In addition, we validated our model predictions with lab experiments using an in-house cancer cell line panel. We finally show the practical applicability of the proposed method by utilizing prior knowledge to infer pathway-drug response associations, opening up the opportunity for elucidating drug action mechanisms. We demonstrate that pathway-response associations can be learned by the proposed model for the well-known EGFR and MEK inhibitors. Availability and implementation: The source code implementing the method is available at http://research.cs.aalto.fi/pml/software/cwkbmf/ . Contacts:muhammad.ammad-ud-din@aalto.fi or samuel.kaski@aalto.fi Supplementary information:Supplementary data are available at Bioinformatics online.Keywords
All Related Versions
Funding Information
- Research Council of Finland
- Cancer Society of Finland
This publication has 31 references indexed in Scilit:
- Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical PropertiesPLOS ONE, 2013
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB ReceptorsCancer Research, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Molecular signatures database (MSigDB) 3.0Bioinformatics, 2011
- Recent Advances in Fragment-Based QSAR and Multi-Dimensional QSAR MethodsInternational Journal of Molecular Sciences, 2010
- Kernel methods for predicting protein-protein interactionsBioinformatics, 2005
- Regularization and Variable Selection Via the Elastic NetJournal of the Royal Statistical Society Series B: Statistical Methodology, 2005
- A Comparison of Methods for Modeling Quantitative Structure−Activity RelationshipsJournal of Medicinal Chemistry, 2004